Publication:
No differences in hemostatic and endothelial activations between haploidentical and matched-donor hematopoietic stem cell transplantation in thalassemia disease

Issued Date

2020-09-04

Resource Type

Article

ISSN

14779560

DOI

10.1186/s12959-020-00232-z

Other identifier(s)

2-s2.0-85091923689

Rights

Mahidol University

Rights Holder(s)

SCOPUS

Bibliographic Citation

Thrombosis Journal. Vol.18, No.1 (2020)

Suggested Citation

Surapong Lertthammakiat, Peerasit Sitthirat, Usanarat Anurathapan, Duantida Songdej, Samart Pakakasama, Ampaiwan Chuansumrit, Nattaphat Putawornsub, Sawitt Sirasittikarn, Sataporn Wantanawijarn, Praguywan Kadegasem, Suradej Hongeng, Nongnuch Sirachainan No differences in hemostatic and endothelial activations between haploidentical and matched-donor hematopoietic stem cell transplantation in thalassemia disease. Thrombosis Journal. Vol.18, No.1 (2020). doi:10.1186/s12959-020-00232-z Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/60083

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Title

No differences in hemostatic and endothelial activations between haploidentical and matched-donor hematopoietic stem cell transplantation in thalassemia disease

Author(s)

Surapong Lertthammakiat
 Peerasit Sitthirat
 Usanarat Anurathapan
 Duantida Songdej
 Samart Pakakasama
 Ampaiwan Chuansumrit
 Nattaphat Putawornsub
 Sawitt Sirasittikarn
 Sataporn Wantanawijarn
 Praguywan Kadegasem
 Suradej Hongeng
 Nongnuch Sirachainan

Other Contributor(s)

Faculty of Medicine, Ramathibodi Hospital, Mahidol University
 Mahidol Wittayanusorn School

Abstract

© 2020 The Author(s). Hemostatic changes and endothelial activations have been recognized in β-thalassemic patients after matched-donor hematopoietic stem cell transplantation (HSCT) but there are limited studies for haploidentical HSCT. This report demonstrates that the levels of hemostatic and endothelial markers, including thrombin antithrombin complex, prothrombin fragment, D-dimer, von Willebrand factor antigen and thrombomodulin levels, were not significantly different between haploidentical and matched-donor HSCT patients.

Keyword(s)

Medicine

Availability

URI

https://repository.li.mahidol.ac.th/handle/20.500.14594/60083

Collections

Scopus 2020